JUAN FRANCISCO
ARENILLAS LARA
CATEDRATICOS DE UNIVERSIDAD
Hospital Universitari de Girona Dr. Josep Trueta
Girona, EspañaPublications en collaboration avec des chercheurs de Hospital Universitari de Girona Dr. Josep Trueta (18)
2023
-
Safety and Efficacy of ApTOLL in Patients with Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial
JAMA Neurology, Vol. 80, Núm. 8, pp. 779-788
2022
-
Dyslipidemias and stroke prevention: recommendations of the Study Group of Cerebrovascular Diseases of the Spanish Society of Neurology
Neurologia, Vol. 37, Núm. 1, pp. 61-72
2021
-
Stroke prevention in patients with arterial hypertension: Recommendations of the Spanish Society of Neurology's Stroke Study Group
Neurologia, Vol. 36, Núm. 6, pp. 462-471
-
Stroke prevention in patients with type 2 diabetes or prediabetes. Recommendations from the Cerebrovascular Diseases Study Group, Spanish Society of Neurology
Neurologia, Vol. 36, Núm. 4, pp. 305-323
2020
-
Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trial
Neurological Research and Practice, Vol. 2, Núm. 1
2019
-
Age- and sex-specific risk profiles and in-hospital mortality in 13,932 Spanish stroke patients
Cerebrovascular Diseases, Vol. 47, Núm. 3-4, pp. 151-164
2017
-
GRECOS Project (Genotyping Recurrence Risk of Stroke): The Use of Genetics to Predict the Vascular Recurrence after Stroke
Stroke, Vol. 48, Núm. 5, pp. 1147-1153
-
Safety and efficacy of thrombectomy in acute ischaemic stroke (REVASCAT): 1-year follow-up of a randomised open-label trial
The Lancet Neurology, Vol. 16, Núm. 5, pp. 369-376
2014
-
Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment
Neurologia
-
Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): A randomised, double-blind phase 2b/3 trial
The Lancet Neurology, Vol. 13, Núm. 5, pp. 453-460
2013
-
Recurrent transient ischaemic attack and early risk of stroke: Data from the PROMAPA study
Journal of Neurology, Neurosurgery and Psychiatry, Vol. 84, Núm. 6, pp. 596-603
2012
-
Prediction of early stroke recurrence in transient ischemic attack patients from the PROMAPA study: A comparison of prognostic risk scores
Cerebrovascular Diseases, Vol. 33, Núm. 2, pp. 182-189
2011
-
Plan de asistencia sanitaria al ICTUS II. 2010
Neurologia, Vol. 26, Núm. 7, pp. 383-396
2008
-
Biological signatures of brain damage associated with high serum ferritin levels in patients with acute ischemic stroke and thrombolytic treatment
Disease Markers, Vol. 25, Núm. 3, pp. 181-188
-
Body temperature and response to thrombolytic therapy in acute ischaemic stroke
European Journal of Neurology, Vol. 15, Núm. 12, pp. 1384-1389
2007
-
Increased body iron stores are associated with poor outcome after thrombolytic treatment in acute stroke
Stroke, Vol. 38, Núm. 1, pp. 90-95
-
Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: A multicenter confirmatory study
Stroke, Vol. 38, Núm. 6, pp. 1855-1859
-
The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome
Stroke, Vol. 38, Núm. 10, pp. 2759-2764